Indegene Ltd (BOM:544172)
₹ 554.75 -14.75 (-2.59%) Market Cap: 133.84 Bil Enterprise Value: 120.47 Bil PE Ratio: 33.48 PB Ratio: 4.26 GF Score: 49/100

Q3 2026 Indegene Ltd Earnings Call Transcript

Jan 30, 2026 / 03:30AM GMT
Release Date Price: ₹482.2 (+2.72%)

Key Points

Positve
  • Indegene Ltd (NSE:INDGN) reported a robust revenue growth of 30.8% year-on-year and 17.1% quarter-on-quarter.
  • The company achieved an adjusted EBITDA margin of 18.5%, marking a 30 basis points improvement quarter-on-quarter.
  • Indegene Ltd (NSE:INDGN) secured seven large deals exceeding $1 million ACV each, showcasing strong new business generation.
  • The company has successfully integrated BioPharm, with positive client responses and no disruption in active engagements.
  • Indegene Ltd (NSE:INDGN) is leveraging AI and Gen AI to enhance productivity and expand its service offerings, positioning itself as a strategic partner in the life sciences industry.
Negative
  • Despite revenue growth, the PAT for the quarter declined by 6.5% year-on-year, with a PAT margin of 10.9%.
  • The company faced elevated costs related to upfront investments and go-live costs in large deals, impacting short-term profitability.
  • Amortization costs increased significantly, impacting the PAT margin and expected to remain elevated for the next three quarters.
  • There is a potential risk of drag on growth from the brand businesses, although the company is optimistic about future prospects.
  • The integration of BioPharm, while progressing well, is still in early stages, and its long-term impact on growth remains to be fully realized.
Operator

Ladies and gentlemen, good morning, and welcome to the Indegene Limited Q3 FY26 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Abhishek Agarwal from Indegene Limited. Thank you, and over to you, sir.

Abhishek Agarwal
Indegene Ltd - Head of Investor Relations

Thank you, moderator. A very good morning to all of you, and thank you for joining us today for Indegene's earnings call conference for the third quarter and nine months ended financial year 2026. Today, we have with us Mr. Manish Gupta, Indegene's Chairman and CEO; and Mr. Suhas Prabhu, CFO, to share the highlights of the business and financials of the quarter.

I hope you have gone through our results release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange website. The transcript of this call will be available in a week's time on the company's website. Please note that today's discussion will be forward-looking in nature and must be viewed in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot